Literature DB >> 12086876

Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit.

Tung O Chan1, Ulrich Rodeck, Andrew M Chan, Alec C Kimmelman, Susan E Rittenhouse, George Panayotou, Philip N Tsichlis.   

Abstract

Phosphoinositide 3-kinase (PI3K) type IA is a heterodimer of a catalytic subunit, p110, and a regulatory subunit, p85. Here we show that p85 contains a GTPase-responsive domain and an inhibitory domain, which together form a molecular switch that regulates PI3K. H-Ras and Rac1 activate PI3K by targeting the GTPase-responsive domain. The stimulatory effect of these molecules, however, is blocked by the inhibitory domain, which functions by binding to tyrosine-phosphorylated molecules and is neutralized by tyrosine phosphorylation. The complementary effects of tyrosine kinases and small GTPases on the p85 molecular switch result in synergy between these two classes of molecules toward the activation of the PI3K/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086876     DOI: 10.1016/s1535-6108(02)00033-8

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  46 in total

1.  The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.

Authors:  Zheng Fu; Eliah Aronoff-Spencer; Jonathan M Backer; Gary J Gerfen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

2.  Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.

Authors:  Lazaros C Foukas; Caroline A Beeton; Jorgen Jensen; Wayne A Phillips; Peter R Shepherd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  The iSH2 domain of PI 3-kinase is a rigid tether for p110 and not a conformational switch.

Authors:  Zheng Fu; Eliah Aronoff-Spencer; Haiyan Wu; Gary J Gerfen; Jonathan M Backer
Journal:  Arch Biochem Biophys       Date:  2004-12-15       Impact factor: 4.013

4.  Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Authors:  Minghao Sun; Jonathan R Hart; Petra Hillmann; Marco Gymnopoulos; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

5.  Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry.

Authors:  Amit Kumar; Miriam Marqués; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2006-10-02       Impact factor: 4.272

6.  Genetic disruption of the PI3K regulatory subunits, p85α, p55α, and p50α, normalizes mutant PTPN11-induced hypersensitivity to GM-CSF.

Authors:  Charles B Goodwin; Zhenyun Yang; Fuqin Yin; Menggang Yu; Rebecca J Chan
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

7.  Acetylcholine-dependent upregulation of TASK-1 channels in thalamic interneurons by a smooth muscle-like signalling pathway.

Authors:  Michael Leist; Susanne Rinné; Maia Datunashvili; Ania Aissaoui; Hans-Christian Pape; Niels Decher; Sven G Meuth; Thomas Budde
Journal:  J Physiol       Date:  2017-08-03       Impact factor: 5.182

8.  Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.

Authors:  Alessandro Giamboi Miraglia; Sara Travaglione; Stefania Meschini; Loredana Falzano; Paola Matarrese; Maria Giovanna Quaranta; Marina Viora; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

9.  Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.

Authors:  Bijay S Jaiswal; Vasantharajan Janakiraman; Noelyn M Kljavin; Subhra Chaudhuri; Howard M Stern; Weiru Wang; Zhengyan Kan; Hashem A Dbouk; Brock A Peters; Paul Waring; Trisha Dela Vega; Denise M Kenski; Krista K Bowman; Maria Lorenzo; Hong Li; Jiansheng Wu; Zora Modrusan; Jeremy Stinson; Michael Eby; Peng Yue; Josh S Kaminker; Frederic J de Sauvage; Jonathan M Backer; Somasekar Seshagiri
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

10.  Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.

Authors:  Miriam Marqués; Amit Kumar; Isabel Cortés; Ana Gonzalez-García; Carmen Hernández; M Carmen Moreno-Ortiz; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.